The Future Care Pathways workstream explores care beyond provision of specific treatment products, widening the focus on to physical and non-physical pathways, the integration and use of digital tools, including artificial intelligence (AI), consideration of mental health, and the science involved in driving behavioural change.
About the workstream
Treatment in hospitals has become more specialised and centralised, and current structures don’t always lend themselves to collaboration around patients with diseases requiring regular and lifelong treatment and a comprehensive, multidisciplinary care team. Significant challenges persist and efforts are needed to future-proof treatment and care.
At the same time, the world becoming more digital provides opportunities for new treatment and care organisation and collaboration tools in order to improve the quality of care, promote patient safety and satisfaction, facilitate communication, and thereby improve the quality of life for patients.
Building on COVID-19 learnings and recognising that in all other aspects of life, technology is becoming more and more integrated, this workstream will explore the role of technology in the future care pathways.
This workstream aims to explore:
- Care beyond provision of specific treatment products,
- Physical and non-physical pathways,
- Patients’ diverse and individual needs,
- The integration and use of digital tools, incl. AI (artificial intelligence),
- Mental health, and
- Behavioural science.
The composition of the workstream aims to reflect the diversity of key actors who have hands-on knowledge of challenges and possible solutions in the thematic area. This includes, but is not limited to: patients, healthcare professionals, industry partners, private companies, policymakers, researchers, and academics.
The general membership profile is built around required skill sets and may evolve throughout the co-creation process. The initial skill sets include the ability to ‘problem map’ salient points and their relationships, requiring:
- Hands-on knowledge of the topic area,
- Genuine willingness to learn about, and actively contribute to, a systems change culture,
- Experienced, analytical, open, hands-on ability to remove stakeholder ‘hat’, and
- Respect of Chatham House Rule and culture of conduct and engagement.
Each workstream brings together around 15 individuals, which is broad enough to ensure a comprehensive overview, while small enough to be workable.
The mandate duration and meeting cadence are subject to collective needs and decisions. However, the preliminary anticipated commitment is three to four (3-4) hours per quarter, and the meetings are designed as virtual workshops requiring active participation.
The first meeting will take place in the first quarter of 2023.
Call for Expression of Interest from the pharmaceutical industry
The application process is now closed.
Should you have any questions, please get in touch with us.